Inappropriate reporting and interpretation of subgroups in the AML-BFM 93 study.
Wheatley
K
K
Hills
R K
RK
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015982:Bias; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D016017:Odds Ratio
D000970:Antineoplastic Agents; D004317:Doxorubicin; D015255:Idarubicin